NuvoBio’s Post

I notice fewer European iPSC companies at the Biotech Showcase @ JP Morgan Healthcare Conference 2025 in San Francisco than in previous years. A European Biotech Investor recently informed me that LSX Inve$tival and the Jefferies London Healthcare Conference are now preferred as an alternative by many. Probable reasons why.... Better experience: Substance abuse issues (Fentanyl) in the Tenderloin District of San Francisco deters attendance. Closer to home: Reduced travel and lower costs for European companies. Tailored connections: Focused networking with European and US investors. Strategic timing: Aligns with Q4 strategy reviews and annual planning. #Biotech #iPSC #JPM2025 #Investival #EuropeanBiotech #Networking #BiotechEvents #GlobalInvestors #Pharma #InvestorConnections #AnnualPlanning #LifeSciences #BiotechCommunity #InnovativeTherapies

Thrilled to be part of the team creating an AI-powered tool for drug discovery! 🧬🔍 As a statistician, I'm excited to contribute to a solution that will impact so many lives. Let's harness the power of AI to revolutionize medicine together! 💊💡 #DrugDiscovery #AI #Revivocell #Statistics"

We’re thrilled to see Compounds Australia, a facility supported by TIA through #NCRIS, take a significant step forward in enhancing their capabilities! Compounds Australia, based at Griffith University, has announced a partnership with Titian Software to implement the Mosaic Sample Management Platform. This new platform will streamline workflows, integrate cutting-edge technologies, and support the growth of their extensive collection of over 1.5 million samples. This partnership highlights the critical role of innovative infrastructure in advancing drug discovery. Congratulations to both teams on this exciting collaboration—we look forward to seeing the impact on research across Australia and beyond! Read more: https://lnkd.in/eFBTs8gp #DrugDiscovery #SampleManagement #Collaboration #Innovation

Exciting News! 🌟 Revivocell receives funding from STFC for our NANOSTACKS CNS modeling tech! Shaping the future of brain modeling!🧠💡 Our AI-driven platform predicts neurotoxicity in drug candidates early on, transforming neuroscience research and drug discovery. #Revivocell #NANOSTACKS #AI #Neuroscience"

✈ In #Boston? Don't miss the LSX - partnering for Life Science eXecutives World Congress USA beginning today at the Hynes Convention Center! See below for more information on Michelle Chen's live presentation. #LSXPartnering #biotech #partnerships

There is an intricate intersection between patenting and clinical trials within the dynamic IP landscape in the life sciences industry. Besty Haanes, SVP of Intellectual Property at IGM Biosciences, Inc., Theresa Raymer, Head of Intellectual Property, Associate General Counsel and Senior Director IP at Recor Medical, and David Dolberg, Senior Director of Intellectual Property at Sanaria Inc. discussed the key factors surrounding clinical trials and patentability, offering strategic guidance to inform filing strategies and timelines. #LSPNFall #Patents #IntellectualProperty

💲Private equity continues to invest in Clinical Trial sites💲 PitchBook's analysis of 2024 first quarter deal activity shows that private equity dollars are streaming into clinical trial sites! The author of Pitchbook's deal activity report write “Clinical trial sites are undoubtedly the hottest category of pharma services as previously [physician practice management]-focused firms pivot into the life sciences category closest to their historical area of expertise,”. Both CRO's and private equity are taking full advantage of the opportunity with American Clinical Research Service acquiring the site network Elixia along with the buyout of Worldwide Clinical Trials by Kohlberg & Co. at the end of 2023. Credit Fierce Pharma #CRO #Privateequity #equity #venturecapitalist #contractresearch #lifescience #friday

⚡️ Cradle Raises $73 Million in Series B Funding Round 💊 Cradle, a platform for AI-powered protein engineering, has raised $73m in Series B funding to respond to rising demand for… ➡️ Read more: https://lnkd.in/eFSYRRxT 🌐 Register for free focused news service covering the latest developments in relation to pharmaceutical supply: https://lnkd.in/eitNb3gD #pharma #pharmanews #APIupdates #offpatent #data #analysis #investments

In the world of therapeutic discovery and development, you can stay ahead—or follow behind.  And the #BioIT partner you choose can make all the difference. At RCH Solutions, we know the key to helping you get the most out of your IT partnerships. Unlock some of those secrets in our latest guide, teaching you how to negotiate effective Science-IT partners and plan for the year ahead: https://loom.ly/kSzzIgM

👨🔬 Drug discovery needs this technology - now Scottish firm is backed with £5 million to deliver it Cytomos said its oversubscribed funding round was led by existing investors Archangel Investors Limited with participation from Old College Capital, Scottish Enterprise and British Business Bank. Full story: https://lnkd.in/e3kjMpKR